期刊文献+

移植物抗宿主病小鼠肝脏及异体CD8^+T细胞趋化因子和趋化因子受体表达分析 被引量:3

Chemokines and chemokine receptors expressed by the liver and allo-reactive CD8^+ T cells in graft-versus-host disease mouse
下载PDF
导出
摘要 为探讨趋化因子及其受体介导的效应性细胞迁移在移植物抗宿主病(graft-versus-host disease,GVHD)发生发展中的重要作用,采用次要组织相容性抗原异配的GVHD小鼠模型,应用流式细胞分选术(FACS)、实时荧光定量聚合酶链反应等方法,分析GVHD靶器官和异体CD8+T细胞趋化因子及受体的表达。肝脏高表达干扰素诱导蛋白-10(IP-10)、干扰素诱导的T细胞趋化因子(ITAC)、γ干扰素诱生单核因子(MIG)、巨噬细胞炎症蛋白(MIP)-1α/β等趋化因子。异体CD8+T细胞上则高表达CXC趋化因子受体(CXCR)3和CC趋化因子受体(CCR)5。随着肝脏趋化因子的表达增加,异体CD8+T细胞迁移浸润的数量也增高。因而趋化因子及异体CD8+T细胞上趋化因子受体的特异对应关系,促使大量异体CD8+T细胞迁移浸润并造成肝脏损伤。 To investigate the important roles of chemokines and chemokine receptors in regulating the migration of effect cells in graft versus-host disease (GVHD), a murine GVHD model to analysis chemokine and chemokine receptor expression in the liver and the allo-CD8^+ T cell was used. By means of flow cytometry analysis (FACS) and real time PCR, we found that liver of GVHD expressed high level of interferon inducible protein 10 (IP-10), interferon-induclble T cell alpha chemoattractant (ITAC), monokine induced by IFN-)' (MIG), and macrophage inflammatory protein (MIP)-1α/β. The infiltrated allo-CD8^+ T cells, accordingly, expressed high CXC chemokine receptor 3 (CXCR3) and CC chemokine receptor 5(CCR5). The number of allo-CD8^+ T cells in liver increased along with the up regulated expression of chemokines, so the relative specific relation of the allo-CD8^+ T cells and the target tissue of GVHD encouraged the migration and infiltration of allo-CD8 ^+ T cells and caused tissue damage.
出处 《现代免疫学》 CAS CSCD 北大核心 2007年第5期397-402,共6页 Current Immunology
基金 国家自然科学基金资助项目(30670911) 上海市重点学科建设项目<医学免疫学>(T0206)
关键词 趋化因子及其趋化因子受体 移植物抗宿主病 异体CD8^+ T细胞 chemokine and chemokine receptor graft-versus-host disease (GVHD) allo-CD8^+ T cell
  • 相关文献

参考文献10

  • 1Belperio JA,Keane MP,Arenberg DA,et al.CXC chemokines in angiogenesis[J].J Leukoc Biol,2000,68(1):1-8.
  • 2Zhang Y,Joe G,Hexner E,et al.Alloreactive memory T cells are responsible for the persistence of graft-versus-host diseasem[J].J Immunol,2005:174(5):3051-3058.
  • 3Luther SA,Cyster JG.Chemokines as regulators of T cell differentiation[J].Nat Immunol,2001,2(2):102-107.
  • 4Castellino F,Huang AY,Altan-Bonnet G,et al.Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction[J].Nature,2006,440(7086):890-895.
  • 5Kim YM,Sachs T,Asavaroengchai W,et al.Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720[J].J Clin Invest,2003,111(5):659-669.
  • 6Charo IF,Ransohoff RM.The many roles of chemokines and chemokine receptors in inflammation[J].N Engl J Med,2006,354(6):610-621.
  • 7Sugerman PB,Faber SB,Willis LM,et al.Kinetics of gene expression in murine cutaneous graft-versus-host disease[J].Am J Pathol,2004,164(6):2189-2202.
  • 8Duffner U,Lu B,Hildebrandt GC,et al.Role of CXCR3-induced donor T-cell migration in acute GVHD[J].Exp Hematol,2003,31(10):897-902.
  • 9武小娟,李春富,唐湘凤,石磊.IL-11在大鼠→小鼠异种骨髓移植中对急性GVHD的预防作用[J].现代免疫学,2005,25(1):28-32. 被引量:6
  • 10Cole KE,Strick CA,Paradis TJ,et al.Interferon-inducible T cell alpha chemoattractant (I-TAC):a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3[J].J Exp Med,1998,87:2009-2021.

二级参考文献14

  • 1Teshima T, Hill GR, Pan L, et al. IL-11 separates graft-versusleukemia effects from graft-versus-host disease after bone marrow transplantation [J] . J Clin Invest, 1999,104:317-325.
  • 2Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin[J] . Blood,1996,88:3230-3239.
  • 3Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease[J]. Blood Rev, 2003,17(4):187-194.
  • 4Opal SM, Keith JC, Palardy JE, et al. Recombinant human interleukin -11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection[J]. J Infect Dis, 2000,181 (2):754-756.
  • 5Shimizu T, Shiratori K, Sawada T,et al. Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice[J]. Pancreas, 2000,21 (2):134-140.
  • 6Venkova K, Keith JC Jr, van Meerveld GB. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats [J] . J Pharmacol Exp Ther, 2004,308 ( 1 ) :206-213.
  • 7Opal SM, Jhung JW, Keith JC Jr, et al. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis [J]. Blood, 1999,93(10):3467-3472.
  • 8van der Meeren A, Mouthon MA, Gaugler MH, et al. Administration of recombinant human IL-11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin[J]. Radiat Res, 2002,157(6):642-649.
  • 9Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines [J]. J Natl Cancer Inst Monogr, 2001,29:16-20.
  • 10Hill GR, Cooke KR, Teshima T, et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation [J]. J Clin Invest, 1998,102:115-123.

共引文献5

同被引文献34

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部